mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0006 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0007 |
mRNA |
SNX-2112 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0008 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.001 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.18 |
0.001 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.59 |
0.001 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.001 |